The immunosuppressive capacity of human mesenchymal stromal cells derived from amnion and bone marrow

Biochemistry and Biophysics Reports

Volumn 8, Issue , 2016, Pages 34-40

  Meesuk, Ladda ^a   Tantrawatpan, Chairat ^a,b   Kheolamai, Pakpoom ^a,b   Manochantr, Sirikul ^a,b  

^a THAMMASAT UNIVERSITY   (Thailand)

^b THAMMASAT UNIVERSITY   (Thailand)

Author keywords

Amnion; IDO; Immunosuppression; MSCs

Indexed keywords

BIOLOGICAL MARKER; CYCLOOXYGENASE 2; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INDOLEAMINE 2,3 DIOXYGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE;

ADIPOCYTE; AMNION DERIVED MESENCHYMAL STROMAL CELL; ARTICLE; BONE MARROW STROMA CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CONTROLLED STUDY; COX 2 GENE; ENZYME RELEASE; GAPDH GENE; GENE; HUMAN; HUMAN CELL; IDO GENE; IMMUNOPHENOTYPING; INOS GENE; LYMPHOCYTE ACTIVATION; MESENCHYMAL STROMA CELL; OSTEOBLAST; T LYMPHOCYTE;

EID: 84982299797     PISSN: None     EISSN: 24055808     Source Type: Journal    
DOI: 10.1016/j.bbrep.2016.07.019     Document Type: Article

References (29)

1. [1] El-Jawhari, J.J., El-Sherbiny, Y.M., Jones, E.A., McGonagle, D., Mesenchymal stem cells, autoimmunity and rheumatoid arthritis. Q. J. Med. 107 (2014), 505–514.
2. [2] Amorin, B., Alegretti, A.P., Valim, V., Pezzi, A., Laureano, A.M., da Silva, M.A., Wieck, A., Silla, L., Mesenchymal stem cell therapy and acute graft-versus-host disease: a review. Hum. Cell 27 (2014), 137–150.
3. [3] Wang, D., Zhang, H., Liang, J., Li, X., Feng, X., Wang, H., Hua, B., Liu, B., Lu, L., Gilkeson, G.S., Silver, R.M., Chen, W., Shi, S., Sun, L., Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience. Cell Transpl. 22 (2013), 2267–2277.
4. [4] Hernigou, P., Pariat, J., Queinnec, S., Homma, Y., Flouzat Lachaniette, C.H., Chevallier, N., Rouard, H., Supercharging irradiated allografts with mesenchymal stem cells improves acetabular bone grafting in revision arthroplasty. Int. Orthop. 38 (2014), 1913–1921.
5. [5] Mattar, P., Bieback, K., Comparing the immunomodulatory properties of bone marrow, adipose tissue, and birth-associated tissue mesenchymal stromal cells. Front. Immunol., 6, 2015, 560.
6. [6] Yoo, K.H., Jang, I.K., Lee, M.W., Kim, H.E., Yang, M.S., Eom, Y., Lee, J.E., Kim, Y.J., Yang, S.K., Jung, H.L., Sung, K.W., Kim, C.W., Koo, H.H., Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell. Immunol. 259 (2009), 150–156.
7. [7] Najar, M., Raicevic, G., Boufker, H.I., Fayyad Kazan, H., De Bruyn, C., Meuleman, N., Bron, D., Toungouz, M., Lagneaux, L., Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: combined comparison of adipose tissue, Wharton's Jelly and bone marrow sources. Cell. Immunol. 264 (2010), 171–179.
8. [8] Zhang, Q., Shi, S., Liu, Y., Uyanne, J., Shi, Y., Le, A.D., Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J. Immunol. 183 (2009), 7787–7798.
9. [9] Sato, K., Ozaki, K., Oh, I., Meguro, A., Hatanaka, K., Nagai, T., Muroi, K., Ozawa, K., Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 109 (2007), 228–234.
10. [10] Ryan, J.M., Barry, F., Murphy, J.M., Mahon, B.P., Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin. Exp. Immunol. 149 (2007), 353–363.
11. [11] Koc, O.N., Lazarus, H.M., Mesenchymal stem cells: heading into the clinic. Bone Marrow Transpl. 27 (2001), 235–239.
12. [12] Stenderup, K., Justesen, J., Clausen, C., Kassem, M., Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33 (2003), 919–926.
13. [13] Manochantr, S., Tantrawatpan, C., Kheolamai, P., U-pratya, Y., Supokawej, A., Issaragrisil, S., Isolation, characterization and neural differentiation potential of amnion derived mesenchymal stem cells. J. Med. Assoc. Thail. 93:Suppl. 7 (2010), S183–S191.
14. [14] Krampera, M., Glennie, S., Dyson, J., Scott, D., Laylor, R., Simpson, E., Dazzi, F., Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101 (2003), 3722–3729.
15. [15] Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Sundberg, B., Bernardo, M.E., Remberger, M., Dini, G., Egeler, R.M., Bacigalupo, A., Fibbe, W., Ringden, O., Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371 (2008), 1579–1586.
16. [16] Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., Marshak, D.R., Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999), 143–147.
17. [17] Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D., Horwitz, E., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8 (2006), 315–317.
18. [18] Bochev, I., Elmadjian, G., Kyurkchiev, D., Tzvetanov, L., Altankova, I., Tivchev, P., Kyurkchiev, S., Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro. Cell Biol. Int. 32 (2008), 384–393.
19. [19] Wagner, W., Roderburg, C., Wein, F., Diehlmann, A., Frankhauser, M., Schubert, R., Eckstein, V., Ho, A.D., Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors. Stem Cells 25 (2007), 2638–2647.
20. [20] De Miguel, M.P., Fuentes-Julian, S., Blazquez-Martinez, A., Pascual, C.Y., Aller, M.A., Arias, J., Arnalich-Montiel, F., Immunosuppressive properties of mesenchymal stem cells: advances and applications. Curr. Mol. Med. 12 (2012), 574–591.
21. [21] Le Blanc, K., Rasmusson, I., Sundberg, B., Gotherstrom, C., Hassan, M., Uzunel, M., Ringden, O., Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363 (2004), 1439–1441.
22. [22] Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P.D., Matteucci, P., Grisanti, S., Gianni, A.M., Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99 (2002), 3838–3843.
23. [23] Tse, W.T., Pendleton, J.D., Beyer, W.M., Egalka, M.C., Guinan, E.C., Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75 (2003), 389–397.
24. [24] Krampera, M., Cosmi, L., Angeli, R., Pasini, A., Liotta, F., Andreini, A., Santarlasci, V., Mazzinghi, B., Pizzolo, G., Vinante, F., Romagnani, P., Maggi, E., Romagnani, S., Annunziato, F., Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24 (2006), 386–398.
25. [25] Meisel, R., Zibert, A., Laryea, M., Gobel, U., Daubener, W., Dilloo, D., Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103 (2004), 4619–4621.
26. [26] Chen, K., Wang, D., Du, W.T., Han, Z.B., Ren, H., Chi, Y., Yang, S.G., Zhu, D., Bayard, F., Han, Z.C., Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism. Clin. Immunol. 135 (2010), 448–458.
27. [27] Kulmacz, R.J., Topography of prostaglandin H synthase. Antiinflammatory agents and the protease-sensitive arginine 253 region. J. Biol. Chem. 264 (1989), 14136–14144.
28. [28] DelaRosa, O., Lombardo, E., Beraza, A., Mancheno-Corvo, P., Ramirez, C., Menta, R., Rico, L., Camarillo, E., Garcia, L., Abad, J.L., Trigueros, C., Delgado, M., Buscher, D., Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells. Tissue Eng. Part A 15 (2009), 2795–2806.
29. [29] Cui, L., Yin, S., Liu, W., Li, N., Zhang, W., Cao, Y., Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E2. Tissue Eng. 13 (2007), 1185–1195.